Resultado de búsqueda
30 de abr. de 2024 · Moderna’s COVID-19 vaccine, called mRNA-1273, was the second vaccine to receive approval from the Food and Drug Administration (FDA). zoranm/Getty Images Moderna, an American biotechnology company based in Cambridge, Massachusetts, began developing its vaccine in January 2020.
Hace 1 día · Here, we demonstrate the effects of intratumoral (IT) injections of the COVID-19 mRNA vaccine on the impairment of tumor growth in mice. Methods: Established B16F10 subcutaneous tumor models in wild type mice were used to evaluate the tumor response from IT administration of mRNA-1273. We compared treatment outcomes, immune composition, and ...
15 de abr. de 2024 · The COVID-19 XBB.1.5-containing mRNA-1273 booster confers robust and diverse neutralizing antibody (nAb) responses against circulating SARS-CoV-2 variants, including JN.1, according to study results published in The Journal of Infectious Diseases.
1 de may. de 2024 · mRNA vaccines have the production advantage that they can be designed swiftly. Moderna designed their mRNA-1273 vaccine for COVID-19 in 2 days. They can also be manufactured faster, more cheaply, and in a more standardized fashion (with fewer error rates in production), which can improve responsiveness to serious outbreaks.
1 de may. de 2024 · Descriptions. SARS-CoV-2 vaccine, mRNA (Moderna) is under investigation as an active immunization against COVID-19 caused by the SARS-CoV-2 virus in patients 6 months of age and older. SARS-CoV-2 (COVID-19) vaccine is used to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS ...
21 de abr. de 2024 · Secretaría de Relaciones Exteriores. Prensa. Aa+. Aa- México recibe cargamento de 1.75 millones de dosis de la vacuna Moderna, gracias a la cooperación con EE. UU. Comunicado No. 371. Secretaría de Relaciones Exteriores | 24 de agosto de 2021 | Comunicado.
18 de abr. de 2024 · Mabel Chan, PharmD, BCACP. April 18, 2024. Although COVID-19 mRNA-1273 vaccination was associated with increased risk for anaphylaxis, myocarditis, and pericarditis, no other reported adverse...
